This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (48)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Neurogenetics  • Neurocutaneous Diseases  • Diagnosis  • Genetic Counseling/ Testing/ Therapy  • Genetic Disorders  • Alert me on articles by topic

Mark H. Hyman, MD; Vicky H. Whittemore, PhD

Arch Neurol. 2000;57:662-665.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

In July 1998, the National Institutes of Health sponsored a consensus conference of international experts to review the literature on tuberous sclerosis complex (TSC). First described in the 1800s, this multiorgan disease has wide-ranging effects on the body, including the brain, kidneys, eyes, and heart. Tuberous sclerosis affects an estimated 40,000 Americans and approximately 2 million people worldwide.¹ The panel provided recommendations on revised diagnostic criteria and surveillance protocols for affected individuals.² Areas for future research were highlighted.

DIAGNOSTIC CRITERIA

The consensus panel arrived at a revised scheme for TSC diagnostic criteria (Table 1). The revision was based on new information from clinical and molecular genetic studies. For example, in contrast with prior diagnostic criteria,³ lymphangiomyomatosis and renal angiomyolipomas can occur together in patients who do not appear to have TSC.⁴ The new criteria eliminated any single finding as pathognomonic for TSC.

Table appears in full text version. . . . [Full Text of this Article]

GENETIC UPDATE

SCREENING AND DIAGNOSTIC EVALUATION

RECOMMENDED AREAS OF FUTURE PURSUITS

CONCLUSIONS

From the Division of General Internal Medicine and Health Services Research, Department of Medicine, University of California, Los Angeles (Dr Hyman), and the National Tuberous Sclerosis Association, Landover, Md (Dr Whittemore).

RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2000;57(5):762-763.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
Bissler et al.
NEJM 2008;358:140-151.
ABSTRACT | FULL TEXT  

The Tuberous Sclerosis Complex.
Crino et al.
NEJM 2006;355:1345-1356.
FULL TEXT  

Hereditary Hormone Excess: Genes, Molecular Pathways, and Syndromes
Marx and Simonds
Endocr. Rev. 2005;26:615-661.
ABSTRACT | FULL TEXT  

Subependymal giant cell tumors in tuberous sclerosis complex
Goh et al.
Neurology 2004;63:1457-1461.
ABSTRACT | FULL TEXT  

Diagnosis of Tuberous Sclerosis Complex
Roach and Sparagana
J Child Neurol 2004;19:643-649.
ABSTRACT  

Brain Abnormalities in Tuberous Sclerosis Complex
DiMario
J Child Neurol 2004;19:650-657.
ABSTRACT  

Non-Neurologic Manifestations of Tuberous Sclerosis Complex
Neal Franz
J Child Neurol 2004;19:690-698.
ABSTRACT  

Critical Role of T-Loop and H-Motif Phosphorylation in the Regulation of S6 Kinase 1 by the Tuberous Sclerosis Complex
Shah and Hunter
J. Biol. Chem. 2004;279:20816-20823.
ABSTRACT | FULL TEXT  

Eye and Kidney: From Clinical Findings to Genetic Explanations
Izzedine et al.
J. Am. Soc. Nephrol. 2003;14:516-529.
FULL TEXT  

Transmantle Dysplasia in Tuberous Sclerosis: Clinical Features and Surgical Outcome in Four Children
Vigliano et al.
J Child Neurol 2002;17:752-758.
ABSTRACT  

Hemimegalencephaly in Tuberous Sclerosis Complex
Galluzzi et al.
J Child Neurol 2002;17:677-680.
ABSTRACT  

Proton MR Spectroscopy of Cortical Tubers in Adults with Tuberous Sclerosis Complex
Mukonoweshuro et al.
Am. J. Neuroradiol. 2001;22:1920-1925.
ABSTRACT | FULL TEXT